Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04732195 · ClinicalTrials.gov registry record · NA
Pilocarpine Microneedles for Sweat Induction (PMN-SI)
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04732195: Completed NA study, sponsored by Emory University.
NCT04732195 is a NA study that has completed, run by Emory University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04732195, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The investigators want to test in this non-randomized clinical trial a new method of administrating Pilocarpine medicine into the skin during the Sweat testing process that does not use any electrical current.
Primary Outcome
Sweat weight in mg collected after application of Pilocarpine Microneedle patch was compared to the forearm of healthy adult subjects with that of standard of care method using pilocarpine iontophoresis
Interventions
- DEVICE Pilocarpine microneedle patch
- DEVICE Pilocarpine Iontophoresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-01-20 |
| Est. Completion | 2022-03-17 |
| Phase | NA |
What the finished NCT04732195 record still lists
NCT04732195 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Pilocarpine microneedle patch is the first listed.
NCT04732195 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04732195 about?
NCT04732195 is a clinical study titled "Pilocarpine Microneedles for Sweat Induction (PMN-SI)". The investigators want to test in this non-randomized clinical trial a new method of administrating Pilocarpine medicine into the skin during the Sweat testing process that does not use any electrical current.
What is the current status of trial NCT04732195?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-01-20. Estimated completion is 2022-03-17.
What interventions are being tested in trial NCT04732195?
The interventions under investigation include: Pilocarpine microneedle patch (DEVICE), Pilocarpine Iontophoresis (DEVICE).
Who is sponsoring clinical trial NCT04732195?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04732195's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI